
Sign up to save your podcasts
Or


Covering a very interesting study this week, which investiaged the PDE4B inhibitor nerandomilast for patients with progressive pulmonary fibrosis (specifically including 325 patients with autoimmune ILD). Would have been yet another ho hum trial if not for the big reveal... have a listen to find out!
Article: https://www.nejm.org/doi/full/10.1056/NEJMoa2503643
By Michael Putman4.9
114114 ratings
Covering a very interesting study this week, which investiaged the PDE4B inhibitor nerandomilast for patients with progressive pulmonary fibrosis (specifically including 325 patients with autoimmune ILD). Would have been yet another ho hum trial if not for the big reveal... have a listen to find out!
Article: https://www.nejm.org/doi/full/10.1056/NEJMoa2503643

502 Listeners

299 Listeners

126 Listeners

3,374 Listeners

1,150 Listeners

120 Listeners

197 Listeners

516 Listeners

70 Listeners

4 Listeners

372 Listeners

183 Listeners

190 Listeners

20 Listeners

5 Listeners